epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Uribel Tabs

methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  TAB: 81.6 mg/9 mg/36.2 mg/10.8 mg/0.12 mg

Special Note

[prescribing info]
Info: not FDA-approved or regulated as a drug

dysuria

[1 tab PO 4x/day]
Info: give with plenty of water

renal dosing

[see below]
renal impairment: not defined, caution advised
HD/PD: not defined, caution advised

hepatic dosing

[see below]
mild-moderate impairment: not defined; severe impairment: not defined, caution advised

Peds Dosing .

Dosage forms:  TAB: 81.6 mg/9 mg/36.2 mg/10.8 mg/0.12 mg

Special Note

[prescribing info]
Info: not FDA-approved or regulated as a drug

dysuria

[>6 yo]
Dose: individualize dose; Info: give with plenty of water

renal dosing

[see below]
renal impairment: not defined, caution advised
HD/PD: not defined, caution advised

hepatic dosing

[see below]
mild-moderate impairment: not defined; severe impairment: not defined, caution advised

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@1f7c9a42
  • hypersensitivity to drug or ingredient
  • G6PD deficiency
  • myocardial ischemia
  • cardiovascular status, unstable
  • caution: hypersensitivity to salicylates
  • caution: hypersensitivity to belladonna alkaloids
  • caution: elderly patients
  • caution: autonomic neuropathy
  • caution: environmental temperature, high
  • caution: fever
  • caution: renal impairment
  • caution: hepatic impairment, severe
  • caution: hyperthyroidism
  • caution: HTN
  • caution: cardiac disease
  • caution: glaucoma
  • caution: GI disease, obstructive
  • caution: GI ulcer
  • caution: myasthenia gravis
  • caution: uropathy, obstructive
  • caution: diarrhea, unexplained

Drug Interactions .

Overview

benzoic acid

urine acidifier

Interaction Characteristics:
  • urine acidifier

hyoscyamine

anticholinergic

Interaction Characteristics:
  • alters gallbladder contraction/motility
  • anticholinergic effects
  • binds to polyvalent cations
  • CNS depression
  • gastric pH modulator
  • tachycardia
Other Info
  • caution advised with concurrent oral drugs requiring rapid onset; hyoscyamine delays gastric emptying, may alter absorption of concomitant oral drugs

methenamine

urinary antiseptic

Interaction Characteristics:
  • impairs immunomodulatory bacterial infective agent
  • urine pH sensitive

methylene blue oral

urinary antiseptic; MAOI

Interaction Characteristics:
  • MAO non-selective inhibitor
  • serotonergic effects (MAOI)

phenyl salicylate

salicylate, non-acetylated

Interaction Characteristics:
  • affects growth hormone diagnostic test results
  • hyperuricemic effects

Contraindicated

  • acetazolamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    acetazolamide
    1 interaction

    Contraindicated

    methenamine + acetazolamide

    contraindicated: combo may decr. methenamine efficacy; may incr. risk of crystalluria (decreased conversion of methenamine to formaldehyde in alkaline urine; sulfonamides may precipitate with formaldehyde)

  • almotriptan
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    almotriptan
    3 interactions

    Contraindicated

    methenamine + almotriptan

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

    Avoid/Use Alternative

    methylene blue oral + almotriptan

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + almotriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • brinzolamide ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    brinzolamide ophthalmic
    1 interaction

    Contraindicated

    methenamine + brinzolamide ophthalmic

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • celecoxib
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    celecoxib
    1 interaction

    Contraindicated

    methenamine + celecoxib

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • chlorothiazide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    chlorothiazide
    1 interaction

    Contraindicated

    methenamine + chlorothiazide

    contraindicated: combo may decr. methenamine efficacy; may incr. risk of crystalluria (decreased conversion of methenamine to formaldehyde in alkaline urine; sulfonamides may precipitate with formaldehyde)

  • chlorthalidone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    chlorthalidone
    1 interaction

    Contraindicated

    methenamine + chlorthalidone

    contraindicated: combo may decr. methenamine efficacy; may incr. risk of crystalluria (decreased conversion of methenamine to formaldehyde in alkaline urine; sulfonamides may precipitate with formaldehyde)

  • codeine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    codeine
    2 interactions

    Contraindicated

    methylene blue oral + codeine

    contraindicated w/in 14 days of methylene blue use; if urgent use, consider alternative, incl. buprenorphine or oxymorphone: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Avoid/Use Alternative

    hyoscyamine + codeine

    avoid combo if antitussive use; otherwise, monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • dabrafenib
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dabrafenib
    1 interaction

    Contraindicated

    methenamine + dabrafenib

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • darunavir
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    darunavir
    1 interaction

    Contraindicated

    methenamine + darunavir

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • deutetrabenazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    deutetrabenazine
    2 interactions

    Contraindicated

    methylene blue oral + deutetrabenazine

    contraindicated w/in 14 days of methylene blue use: combo may incr. risk of serotonin syndrome, other adverse effects (increased synaptic monoamine neurotransmitters; methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + deutetrabenazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dorzolamide ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dorzolamide ophthalmic
    1 interaction

    Contraindicated

    methenamine + dorzolamide ophthalmic

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • fosamprenavir
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    fosamprenavir
    1 interaction

    Contraindicated

    methenamine + fosamprenavir

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • glimepiride
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    glimepiride
    1 interaction

    Contraindicated

    methenamine + glimepiride

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • glipizide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    glipizide
    1 interaction

    Contraindicated

    methenamine + glipizide

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • glyburide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    glyburide
    1 interaction

    Contraindicated

    methenamine + glyburide

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • hydrochlorothiazide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    hydrochlorothiazide
    2 interactions

    Contraindicated

    methenamine + hydrochlorothiazide

    contraindicated: combo may decr. methenamine efficacy; may incr. risk of crystalluria (decreased conversion of methenamine to formaldehyde in alkaline urine; sulfonamides may precipitate with formaldehyde)

    Caution Advised

    hyoscyamine + hydrochlorothiazide

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • indapamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    indapamide
    1 interaction

    Contraindicated

    methenamine + indapamide

    contraindicated: combo may decr. methenamine efficacy; may incr. risk of crystalluria (decreased conversion of methenamine to formaldehyde in alkaline urine; sulfonamides may precipitate with formaldehyde)

  • linezolid
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    linezolid
    1 interaction

    Contraindicated

    methylene blue oral + linezolid

    contraindicated w/in 2wk of methylene blue use; hold methylene blue use if urgent use; monitor serotonin syndrome sx x2wk after methylene blue use D/C or 24h after last linezolid dose: combo may incr. risk of serotonin syndrome (additive effects, both agents have MAOI activity)

  • mafenide topical
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    mafenide topical
    1 interaction

    Contraindicated

    methenamine + mafenide topical

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • meperidine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    meperidine
    2 interactions

    Contraindicated

    methylene blue oral + meperidine

    contraindicated w/in 14 days of methylene blue use: combo may incr. risk of respiratory depression, serotonin syndrome, hypotension (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + meperidine

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • metolazone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    metolazone
    1 interaction

    Contraindicated

    methenamine + metolazone

    contraindicated: combo may decr. methenamine efficacy; may incr. risk of crystalluria (decreased conversion of methenamine to formaldehyde in alkaline urine; sulfonamides may precipitate with formaldehyde)

  • morphine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    morphine
    2 interactions

    Contraindicated

    methylene blue oral + morphine

    contraindicated w/in 14 days of methylene blue use; if urgent use, consider alternative, incl. buprenorphine, hydromorphone, or oxymorphone: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + morphine

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • opicapone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    opicapone
    2 interactions

    Contraindicated

    methylene blue oral + opicapone

    contraindicated: combo may incr. endogenous catecholamine levels, risk of HTN, tachycardia, arrhythmias, other adverse effects (possible dual inhibition of catecholamine metabolism)

    Monitor/Modify Tx

    hyoscyamine + opicapone

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • opium
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    opium
    2 interactions

    Contraindicated

    methylene blue oral + opium

    contraindicated w/in 14 days of methylene blue use: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + opium

    separate admin. by 1h; monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may decr. hyoscyamine levels, efficacy; may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (mechanism unknown; additive effects)

  • ozanimod
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ozanimod
    1 interaction

    Contraindicated

    methylene blue oral + ozanimod

    contraindicated w/in 14 days of methylene blue use: combo may incr. or decr. ozanimod and active metabolite levels, incr. risk of AV block, bradycardia, QT and PR interval prolongation, cardiac arrhythmias, serious infection, other adverse effects or decr. efficacy (monoamine oxidase (MAO) possibly inhibited, altered conversion to active metabolite)

  • potassium chloride
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    potassium chloride
    1 interaction

    Contraindicated

    hyoscyamine + potassium chloride

    contraindicated w/ solid potassium formulations; consider alternative, incl. liquid potassium formulations: combo may incr. risk of GI ulcerative, stenotic lesions (GI transit delayed, increased local exposure to high potassium concentration)

  • potassium citrate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    potassium citrate
    2 interactions

    Contraindicated

    hyoscyamine + potassium citrate

    contraindicated w/ solid potassium formulations; consider alternative, incl. liquid potassium formulations: combo may incr. risk of GI ulcerative, stenotic lesions (GI transit delayed, increased local exposure to high potassium concentration)

    Avoid/Use Alternative

    methenamine + potassium citrate

    use alternative or monitor urine pH: combo may decr. methenamine efficacy (decreased conversion of methenamine to formaldehyde in alkaline urine)

  • rasagiline
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    rasagiline
    2 interactions

    Contraindicated

    methylene blue oral + rasagiline

    contraindicated w/in 14 days of rasagiline use: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + rasagiline

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • rizatriptan
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    rizatriptan
    2 interactions

    Contraindicated

    methylene blue oral + rizatriptan

    contraindicated w/in 14 days of methylene blue use: combo may incr. rizatriptan levels, risk of serotonin syndrome, other adverse effects (monoamine oxidase (MAO) possibly inhibited, additive effects)

    Caution Advised

    hyoscyamine + rizatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • safinamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    safinamide
    2 interactions

    Contraindicated

    methylene blue oral + safinamide

    contraindicated w/in 14 days of safinamide or methylene blue use: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + safinamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • selegiline
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    selegiline
    2 interactions

    Contraindicated

    methylene blue oral + selegiline

    contraindicated w/in 14 days of selegiline use: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + selegiline

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • silver sulfadiazine topical
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    silver sulfadiazine topical
    1 interaction

    Contraindicated

    methenamine + silver sulfadiazine topical

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • sulfacetamide ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sulfacetamide ophthalmic
    1 interaction

    Contraindicated

    methenamine + sulfacetamide ophthalmic

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • sulfacetamide topical
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sulfacetamide topical
    1 interaction

    Contraindicated

    methenamine + sulfacetamide topical

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • sulfadiazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sulfadiazine
    1 interaction

    Contraindicated

    methenamine + sulfadiazine

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • sulfamethoxazole
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sulfamethoxazole
    1 interaction

    Contraindicated

    methenamine + sulfamethoxazole

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • sulfasalazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sulfasalazine
    1 interaction

    Contraindicated

    methenamine + sulfasalazine

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • sumatriptan
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sumatriptan
    2 interactions

    Contraindicated

    methylene blue oral + sumatriptan

    contraindicated w/in 14 days of methylene blue use: combo may incr. sumatriptan levels, risk of serotonin syndrome, other adverse effects (monoamine oxidase (MAO) possibly inhibited, additive effects)

    Caution Advised

    hyoscyamine + sumatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tapentadol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tapentadol
    2 interactions

    Contraindicated

    methylene blue oral + tapentadol

    contraindicated w/in 14 days of methylene blue use; if urgent use, consider alternative, incl. buprenorphine or oxymorphone: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + tapentadol

    monitor respiratory rate, BP; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension (including orthostasis, syncope), severe constipation, paralytic ileus, urinary retention (additive effects)

  • tetrabenazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tetrabenazine
    2 interactions

    Contraindicated

    methylene blue oral + tetrabenazine

    contraindicated w/in 14 days of methylene blue use: combo may incr. risk of serotonin syndrome, other adverse effects (increased synaptic monoamine neurotransmitters; methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + tetrabenazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tipranavir
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tipranavir
    1 interaction

    Contraindicated

    methenamine + tipranavir

    contraindicated: combo may incr. risk of crystalluria (sulfonamides may precipitate with formaldehyde)

  • tramadol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tramadol
    2 interactions

    Contraindicated

    methylene blue oral + tramadol

    contraindicated w/in 14 days of methylene blue use: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + tramadol

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • varicella vaccine, live
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    varicella vaccine, live
    1 interaction

    Contraindicated

    phenyl salicylate + varicella vaccine, live

    contraindicated w/in 6wk of varicella vaccine: combo may incr. risk of Reye syndrome; no reports with vaccine but associated with wild-type varicella infection (mechanism unknown)

  • zolmitriptan
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    zolmitriptan
    2 interactions

    Contraindicated

    methylene blue oral + zolmitriptan

    contraindicated w/in 14 days of methylene blue use: combo may incr. zolmitriptan levels, risk of serotonin syndrome, other adverse effects (monoamine oxidase (MAO) possibly inhibited, additive effects)

    Caution Advised

    hyoscyamine + zolmitriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zonisamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    zonisamide
    2 interactions

    Contraindicated

    methenamine + zonisamide

    contraindicated: combo may decr. methenamine efficacy; may incr. risk of crystalluria (decreased conversion of methenamine to formaldehyde in alkaline urine; sulfonamides may precipitate with formaldehyde)

    Caution Advised

    hyoscyamine + zonisamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

Avoid/Use Alternative

  • 5-HTP
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    5-HTP
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + 5-HTP

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + 5-HTP

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • aclidinium inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    aclidinium inhaled
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + aclidinium inhaled

    avoid combo: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • alfentanil
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    alfentanil
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + alfentanil

    use alternative or monitor BP, respiratory rate, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome, HTN (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + alfentanil

    monitor BP, respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, severe constipation, paralytic ileus, urinary retention (additive effects)

  • aluminum hydroxide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    aluminum hydroxide
    2 interactions

    Avoid/Use Alternative

    methenamine + aluminum hydroxide

    use alternative or monitor urine pH: combo may decr. methenamine efficacy (decreased conversion of methenamine to formaldehyde in alkaline urine)

    Monitor/Modify Tx

    hyoscyamine + aluminum hydroxide

    separate admin. w/ oral hyoscyamine: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • amitriptyline
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    amitriptyline
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + amitriptyline

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + amitriptyline

    monitor HR; consider decr. dose of one or both drugs: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, hyperthermia, anticholinergic adverse effects (additive effects)

  • amoxapine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    amoxapine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + amoxapine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + amoxapine

    monitor HR: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • amphetamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    amphetamine
    3 interactions

    Avoid/Use Alternative

    methylene blue oral + amphetamine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration; decr. amphetamine start dose: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + amphetamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

    Caution Advised

    benzoic acid + amphetamine

    caution advised: combo may decr. amphetamine levels, efficacy (renal excretion increased at lower urine pH)

  • BCG live intravesical
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    BCG live intravesical
    1 interaction

    Avoid/Use Alternative

    methenamine + BCG live intravesical

    avoid combo: combo may decr. BCG live intravesical efficacy (antibacterial effect may interfere with BCG activity)

  • belladonna alkaloids
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    belladonna alkaloids
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + belladonna alkaloids

    avoid combo: combo may incr. risk of anticholinergic adverse effects (additive effects, duplicate therapy, belladonna alkaloids contain hyoscyamine)

  • benztropine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    benztropine
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + benztropine

    consider alternative or monitor HR: combo may incr. risk of life-threatening anticholinergic adverse effects, including constipation, paralytic ileus, hyperthermia, tachycardia (additive effects)

  • bromocriptine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    bromocriptine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + bromocriptine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + bromocriptine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • buprenorphine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    buprenorphine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + buprenorphine

    use alternative or monitor respiratory rate, serotonin syndrome sx w/in 14 days of methylene blue use, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + buprenorphine

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • buspirone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    buspirone
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + buspirone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + buspirone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • butalbital
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    butalbital
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + butalbital

    avoid combo: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • butorphanol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    butorphanol
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + butorphanol

    use alternative or monitor respiratory rate, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + butorphanol

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • calcium carbonate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    calcium carbonate
    2 interactions

    Avoid/Use Alternative

    methenamine + calcium carbonate

    use alternative or monitor urine pH: combo may decr. methenamine efficacy (decreased conversion of methenamine to formaldehyde in alkaline urine)

    Monitor/Modify Tx

    hyoscyamine + calcium carbonate

    separate administration with oral hyoscyamine: combo may decrease hyoscyamine levels, efficacy (absorption decreased via chelation)

  • carbamazepine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    carbamazepine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + carbamazepine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + carbamazepine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • cholera vaccine, live
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cholera vaccine, live
    1 interaction

    Avoid/Use Alternative

    methenamine + cholera vaccine, live

    avoid vaccine until at least 14 days after methenamine course complete: combo may result in inadequate vaccine response (antibiotic effect may inactivate vaccine)

  • citalopram
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    citalopram
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + citalopram

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + citalopram

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • clomipramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    clomipramine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + clomipramine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + clomipramine

    monitor HR; consider decr. dose of one or both drugs: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • clonidine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    clonidine
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + clonidine

    if ADHD use, avoid combo; otherwise, caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • clozapine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    clozapine
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + clozapine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment, severe constipation, paralytic ileus (including life-threatening), other anticholinergic adverse effects (additive effects)

  • cocaine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cocaine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + cocaine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + cocaine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • cyclobenzaprine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cyclobenzaprine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + cyclobenzaprine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + cyclobenzaprine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • desipramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    desipramine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + desipramine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + desipramine

    monitor HR; consider decr. dose of one or both drugs: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • desvenlafaxine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    desvenlafaxine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + desvenlafaxine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + desvenlafaxine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dexmethylphenidate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dexmethylphenidate
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + dexmethylphenidate

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + dexmethylphenidate

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • dextroamphetamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dextroamphetamine
    3 interactions

    Avoid/Use Alternative

    methylene blue oral + dextroamphetamine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration; decr. dextroamphetamine start dose: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + dextroamphetamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

    Caution Advised

    benzoic acid + dextroamphetamine

    caution advised: combo may decr. dextroamphetamine levels, efficacy (renal excretion increased at lower urine pH)

  • dextromethorphan
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dextromethorphan
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + dextromethorphan

    use alternative or monitor serotonin syndrome sx w/in 14 days of methylene blue use, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • dichlorphenamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dichlorphenamide
    2 interactions

    Avoid/Use Alternative

    methenamine + dichlorphenamide

    use alternative or monitor urine pH: combo may decr. methenamine efficacy (decreased conversion of methenamine to formaldehyde in alkaline urine)

    Caution Advised

    hyoscyamine + dichlorphenamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dihydrocodeine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dihydrocodeine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + dihydrocodeine

    use alternative or monitor respiratory rate, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + dihydrocodeine

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • dihydroergotamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dihydroergotamine
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + dihydroergotamine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • doxepin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    doxepin
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + doxepin

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + doxepin

    monitor HR: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, hyperthermia, anticholinergic adverse effects (additive effects)

  • doxepin topical
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    doxepin topical
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + doxepin topical

    avoid combo w/in 14 days of methylene blue use: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + doxepin topical

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • doxylamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    doxylamine
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + doxylamine

    avoid combo if doxylamine use for pregnancy-related nausea/vomiting; otherwise, caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • dronabinol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dronabinol
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + dronabinol

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, tachycardia (additive effects)

  • duloxetine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    duloxetine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + duloxetine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + duloxetine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • eletriptan
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    eletriptan
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + eletriptan

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + eletriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • eluxadoline
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    eluxadoline
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + eluxadoline

    avoid combo: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • entacapone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    entacapone
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + entacapone

    avoid combo: combo may incr. catecholamine levels, risk of HTN, tachycardia, arrhythmias, other adverse effects (possible dual inhibition of catecholamine metabolism)

    Caution Advised

    hyoscyamine + entacapone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ephedra
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ephedra
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + ephedra

    avoid combo: combo may incr. risk of tachycardia (additive effects)

  • epinephrine inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + epinephrine inhaled

    avoid combo: combo may incr. risk of tachycardia (additive effects)

  • ergotamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ergotamine
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + ergotamine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • escitalopram
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    escitalopram
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + escitalopram

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + escitalopram

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ethanol (alcoholic beverage)
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + ethanol (alcoholic beverage)

    avoid combo: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • ethanol injection
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ethanol injection
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + ethanol injection

    use alternative or monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • fenfluramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    fenfluramine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + fenfluramine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + fenfluramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • fentanyl
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    fentanyl
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + fentanyl

    use alternative or monitor respiratory rate, serotonin syndrome sx w/in 14 days of methylene blue use, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + fentanyl

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • fluoxetine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    fluoxetine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + fluoxetine

    use alternative or monitor serotonin syndrome sx w/in 14 days of methylene blue or 5wk of fluoxetine use, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + fluoxetine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • fluvoxamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    fluvoxamine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + fluvoxamine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + fluvoxamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • frovatriptan
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    frovatriptan
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + frovatriptan

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + frovatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • glucagon
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    glucagon
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + glucagon

    avoid combo if glucagon used as radiologic diagnostic aid: combo may incr. risk of severe constipation, paralytic ileus, other GI adverse effects (additive effects)

  • glycopyrronium topical
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    glycopyrronium topical
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + glycopyrronium topical

    avoid combo: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • granisetron
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    granisetron
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + granisetron

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • haloperidol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    haloperidol
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + haloperidol

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • hydrocodone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    hydrocodone
    2 interactions

    Avoid/Use Alternative

    hyoscyamine + hydrocodone

    avoid combo if antitussive use; otherwise, monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

    methylene blue oral + hydrocodone

    avoid combo w/in 14 days of methylene blue use: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • hydromorphone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    hydromorphone
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + hydromorphone

    use alternative or monitor respiratory rate, serotonin syndrome sx w/in 14 days of methylene blue use, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + hydromorphone

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • hyoscyamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    hyoscyamine
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + hyoscyamine

    avoid combo: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, anticholinergic and other adverse effects (additive effects, duplicate therapy)

  • imipramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    imipramine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + imipramine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + imipramine

    monitor HR; consider decr. dose of one or both drugs: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • isocarboxazid
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    isocarboxazid
    2 interactions

    Avoid/Use Alternative

    hyoscyamine + isocarboxazid

    use alternative during and x10 days after isocarboxazid use: combo may incr. risk of CNS depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

    methylene blue oral + isocarboxazid

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • isoniazid
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    isoniazid
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + isoniazid

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, both agents have MAOI activity)

  • kava
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    kava
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + kava

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • kratom
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    kratom
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + kratom

    use alternative or monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • levomilnacipran
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    levomilnacipran
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + levomilnacipran

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + levomilnacipran

    monitor HR: combo may incr. risk of CNS depression, psychomotor impairment, tachycardia (additive effects)

  • levorphanol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    levorphanol
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + levorphanol

    use alternative or monitor respiratory rate, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + levorphanol

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • lisdexamfetamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lisdexamfetamine
    3 interactions

    Avoid/Use Alternative

    methylene blue oral + lisdexamfetamine

    use alternative or decr. lisdexamfetamine start dose; monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + lisdexamfetamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

    Caution Advised

    benzoic acid + lisdexamfetamine

    caution advised: combo may decr. dextroamphetamine levels, efficacy (renal excretion increased at lower urine pH)

  • lithium
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lithium
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + lithium

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • macimorelin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    macimorelin
    1 interaction

    Avoid/Use Alternative

    phenyl salicylate + macimorelin

    avoid combo or D/C phenyl salicylate, allowing sufficient washout time before diagnostic test: combo may interfere with test results (phenyl salicylate may affect pituitary secretion of growth hormone)

  • magnesium carbonate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    magnesium carbonate
    2 interactions

    Avoid/Use Alternative

    methenamine + magnesium carbonate

    use alternative or monitor urine pH: combo may decr. methenamine efficacy (decreased conversion of methenamine to formaldehyde in alkaline urine)

    Monitor/Modify Tx

    hyoscyamine + magnesium carbonate

    separate administration with oral hyoscyamine: combo may decrease hyoscyamine levels, efficacy (absorption decreased via chelation)

  • magnesium hydroxide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    magnesium hydroxide
    2 interactions

    Avoid/Use Alternative

    methenamine + magnesium hydroxide

    use alternative or monitor urine pH: combo may decr. methenamine efficacy (decreased conversion of methenamine to formaldehyde in alkaline urine)

    Monitor/Modify Tx

    hyoscyamine + magnesium hydroxide

    separate administration with oral hyoscyamine: combo may decrease hyoscyamine levels, efficacy (absorption decreased via chelation)

  • metaxalone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    metaxalone
    2 interactions

    Avoid/Use Alternative

    hyoscyamine + metaxalone

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

    methylene blue oral + metaxalone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • methadone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methadone
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + methadone

    avoid combo w/in 14 days of methylene blue use: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + methadone

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • methamphetamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methamphetamine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + methamphetamine

    use alternative or decr. methamphetamine start dose; monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    benzoic acid + methamphetamine

    caution advised: combo may decr. methamphetamine levels, efficacy (renal excretion increased at lower urine pH)

  • methazolamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methazolamide
    1 interaction

    Avoid/Use Alternative

    methenamine + methazolamide

    use alternative or monitor urine pH: combo may decr. methenamine efficacy; may incr. risk of crystalluria (decreased conversion of methenamine to formaldehyde in alkaline urine; sulfonamides may precipitate with formaldehyde)

  • methylene blue injection
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methylene blue injection
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + methylene blue injection

    avoid combo: combo may incr. risk of serotonin syndrome, other adverse effects (additive effects, methylene blue reversibly inhibits monoamine oxidase; duplicate therapy)

  • methylergonovine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methylergonovine
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + methylergonovine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • methylphenidate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methylphenidate
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + methylphenidate

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + methylphenidate

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • metoclopramide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    metoclopramide
    2 interactions

    Avoid/Use Alternative

    hyoscyamine + metoclopramide

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

    methylene blue oral + metoclopramide

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • mexiletine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    mexiletine
    2 interactions

    Avoid/Use Alternative

    benzoic acid + mexiletine

    avoid combo: combo may decr. mexiletine levels, efficacy (renal excretion increased at lower urine pH)

    Caution Advised

    hyoscyamine + mexiletine

    caution advised: combo may decr. peak mexiletine levels, delay antiarrhythmic onset (absorption delayed)

  • midazolam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    midazolam
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + midazolam

    use alternative or monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • milnacipran
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    milnacipran
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + milnacipran

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + milnacipran

    monitor HR: combo may incr. risk of CNS depression, psychomotor impairment, tachycardia (additive effects)

  • mirtazapine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    mirtazapine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + mirtazapine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + mirtazapine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • nalbuphine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    nalbuphine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + nalbuphine

    use alternative or monitor respiratory rate, serotonin syndrome sx w/in 14 days of methylene blue use, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + nalbuphine

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • naratriptan
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    naratriptan
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + naratriptan

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + naratriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • nortriptyline
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    nortriptyline
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + nortriptyline

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + nortriptyline

    monitor HR; consider decr. dose of one or both drugs: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • olanzapine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    olanzapine
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + olanzapine

    consider alternative or monitor BP: combo may incr. risk of life-threatening anticholinergic adverse effects, including constipation, paralytic ileus, hyperthermia, CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • oliceridine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    oliceridine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + oliceridine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + oliceridine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, severe constipation, paralytic ileus, urinary retention (additive effects)

  • ondansetron
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ondansetron
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + ondansetron

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • oxybate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    oxybate
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + oxybate

    use alternative or monitor respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, syncope (additive effects)

  • oxycodone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    oxycodone
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + oxycodone

    avoid combo w/in 14 days of methylene blue use: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + oxycodone

    monitor respiratory rate; decr. oxycodone start dose by at least 50%, consider decr. hyoscyamine dose, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • oxymorphone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    oxymorphone
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + oxymorphone

    use alternative or monitor respiratory rate, serotonin syndrome sx w/in 14 days of methylene blue use, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + oxymorphone

    monitor respiratory rate; decr. oxymorphone start dose by at least 50%, consider decr. hyoscyamine dose, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • palonosetron
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    palonosetron
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + palonosetron

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • paroxetine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    paroxetine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + paroxetine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + paroxetine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • pentazocine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pentazocine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + pentazocine

    use alternative or monitor respiratory rate, serotonin syndrome sx w/in 14 days of methylene blue use, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + pentazocine

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • phenelzine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    phenelzine
    2 interactions

    Avoid/Use Alternative

    hyoscyamine + phenelzine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

    methylene blue oral + phenelzine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • pramlintide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pramlintide
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + pramlintide

    consider alternative: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • primaquine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    primaquine
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + primaquine

    monitor ECG, CBC; consider alternative if also CYP2D6 intermediate or poor metabolizer or if also combined with strong CYP2D6 inhibitor: combo may incr. primaquine levels, risk of QT prolongation, cardiac arrhythmias, myelosuppression, other adverse effects (monoamine oxidase possibly inhibited)

  • procarbazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    procarbazine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + procarbazine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue and procarbazine inhibit monoamine oxidase)

    Caution Advised

    hyoscyamine + procarbazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • promethazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    promethazine
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + promethazine

    use alternative or monitor respiratory rate; decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • protriptyline
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    protriptyline
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + protriptyline

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + protriptyline

    monitor HR; consider decr. dose of one or both drugs: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, hyperthermia, anticholinergic adverse effects (additive effects)

  • remifentanil
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    remifentanil
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + remifentanil

    use alternative or monitor respiratory rate, serotonin syndrome sx w/in 14 days of methylene blue use, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + remifentanil

    monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • revefenacin inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    revefenacin inhaled
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + revefenacin inhaled

    avoid combo: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • rivastigmine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    rivastigmine
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + rivastigmine

    use alternative: combo may decr. efficacy of both drugs (antagonistic effects)

  • ropeginterferon alfa-2b
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ropeginterferon alfa-2b
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + ropeginterferon alfa-2b

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • SAMe
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    SAMe
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + SAMe

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • scopolamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    scopolamine
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + scopolamine

    use alternative: combo may increase risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • selegiline transdermal
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    selegiline transdermal
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + selegiline transdermal

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + selegiline transdermal

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • sertraline
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sertraline
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + sertraline

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + sertraline

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • sodium bicarbonate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sodium bicarbonate
    1 interaction

    Avoid/Use Alternative

    methenamine + sodium bicarbonate

    use alternative or monitor urine pH: combo may decr. methenamine efficacy (decreased conversion of methenamine to formaldehyde in alkaline urine)

  • sodium citrate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sodium citrate
    1 interaction

    Avoid/Use Alternative

    methenamine + sodium citrate

    use alternative or monitor urine pH: combo may decr. methenamine efficacy (decreased conversion of methenamine to formaldehyde in alkaline urine)

  • sofpironium topical
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sofpironium topical
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + sofpironium topical

    avoid combo: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • St. John's wort
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    St. John's wort
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + St. John's wort

    avoid combo w/in 14 days of methylene blue use: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • sufentanil
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sufentanil
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + sufentanil

    use alternative or monitor respiratory rate, serotonin syndrome sx w/in 14 days of methylene blue use, especially during initiation/titration: combo may incr. risk of respiratory depression, serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + sufentanil

    monitor respiratory rate; decr. sufentanil start dose, consider decr. hyoscyamine dose, use lowest effective doses: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

  • tedizolid
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tedizolid
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + tedizolid

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, both drugs inhibit monoamine oxidase)

  • thalidomide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    thalidomide
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + thalidomide

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tiotropium inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tiotropium inhaled
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + tiotropium inhaled

    avoid combo: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • tolcapone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tolcapone
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + tolcapone

    avoid combo: combo may incr. catecholamine levels, risk of HTN, tachycardia, arrhythmias, other adverse effects (possible dual inhibition of catecholamine metabolism)

    Caution Advised

    hyoscyamine + tolcapone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • topiramate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    topiramate
    2 interactions

    Avoid/Use Alternative

    methenamine + topiramate

    use alternative or monitor urine pH: combo may decr. methenamine efficacy (decreased conversion of methenamine to formaldehyde in alkaline urine)

    Caution Advised

    hyoscyamine + topiramate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • tradipitant
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tradipitant
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + tradipitant

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tranylcypromine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tranylcypromine
    2 interactions

    Avoid/Use Alternative

    hyoscyamine + tranylcypromine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention (additive effects)

    methylene blue oral + tranylcypromine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • trazodone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    trazodone
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + trazodone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + trazodone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • trimethobenzamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    trimethobenzamide
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + trimethobenzamide

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • trimipramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    trimipramine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + trimipramine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + trimipramine

    monitor HR: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • typhoid vaccine, live
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    typhoid vaccine, live
    1 interaction

    Avoid/Use Alternative

    methenamine + typhoid vaccine, live

    avoid vaccine course during and w/in 72h of methenamine use; if possible, delay methenamine until at least 72h after last vaccine dose: combo may result in inadequate vaccine response (antibiotic effect may inactivate vaccine)

  • umeclidinium inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    umeclidinium inhaled
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + umeclidinium inhaled

    avoid combo: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • valbenazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    valbenazine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + valbenazine

    avoid combo w/in 14 days of methylene blue use: combo may incr. risk of serotonin syndrome; may decr. valbenazine efficacy (increased synaptic monoamine neurotransmitters; methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + valbenazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • venlafaxine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    venlafaxine
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + venlafaxine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + venlafaxine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • vilazodone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    vilazodone
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + vilazodone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + vilazodone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • vortioxetine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    vortioxetine
    1 interaction

    Avoid/Use Alternative

    methylene blue oral + vortioxetine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • yohimbe
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    yohimbe
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + yohimbe

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue and yohimbe inhibit monoamine oxidase)

    Monitor/Modify Tx

    hyoscyamine + yohimbe

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ziprasidone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ziprasidone
    2 interactions

    Avoid/Use Alternative

    methylene blue oral + ziprasidone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + ziprasidone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • zuranolone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    zuranolone
    1 interaction

    Avoid/Use Alternative

    hyoscyamine + zuranolone

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Monitor/Modify Tx

  • albuterol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + albuterol

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • albuterol inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + albuterol inhaled

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • aldesleukin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    aldesleukin
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + aldesleukin

    withhold aldesleukin if mod-severe somnolence occurs; otherwise, caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • alprazolam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    alprazolam
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + alprazolam

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • arformoterol inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + arformoterol inhaled

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • armodafinil
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + armodafinil

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • atomoxetine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + atomoxetine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • atropine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    atropine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + atropine

    monitor HR; separate admin. by 1h: combo may decr. hyoscyamine levels, efficacy; may incr. risk of tachycardia, anticholinergic adverse effects (mechanism unknown; additive effects)

  • benzphetamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + benzphetamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • bismuth subsalicylate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + bismuth subsalicylate

    separate admin. by 1h: combo may decr. hyoscyamine levels, efficacy (mechanism unknown)

  • black cohosh
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    black cohosh
    1 interaction

    Monitor/Modify Tx

    methylene blue oral + black cohosh

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • brimonidine topical
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    brimonidine topical
    2 interactions

    Monitor/Modify Tx

    methylene blue oral + brimonidine topical

    monitor BP: combo may incr. brimonidine levels, risk of hypotension, other adverse effects (monoamine oxidase (MAO) possibly inhibited)

    Caution Advised

    hyoscyamine + brimonidine topical

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • bupropion
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    methylene blue oral + bupropion

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome (possible additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • caffeine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + caffeine

    monitor HR; avoid excessive caffeine intake: combo may incr. risk of tachycardia (additive effects)

  • caffeine citrate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + caffeine citrate

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • calcium acetate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    calcium acetate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + calcium acetate

    separate admin. w/ oral hyoscyamine: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • calcium citrate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    calcium citrate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + calcium citrate

    separate admin. w/ oral hyoscyamine: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • calcium gluconate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    calcium gluconate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + calcium gluconate

    separate admin. w/ oral hyoscyamine: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • cannabis
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + cannabis

    monitor HR: combo may incr. risk of CNS depression, psychomotor impairment, tachycardia (additive effects)

  • chlorpromazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + chlorpromazine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • chromium
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    chromium
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + chromium

    separate admin. w/ oral hyoscyamine: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • clobazam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    clobazam
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + clobazam

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • clonazepam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    clonazepam
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + clonazepam

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • clorazepate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    clorazepate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + clorazepate

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • daridorexant
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    daridorexant
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + daridorexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • desflurane
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + desflurane

    consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • dexmedetomidine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + dexmedetomidine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dexmedetomidine injection
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + dexmedetomidine injection

    monitor respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • diazepam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    diazepam
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + diazepam

    monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • dicyclomine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dicyclomine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + dicyclomine

    monitor HR: combo may incr. risk of tachycardia, anticholinergic adverse effects (additive effects)

  • diethylpropion
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + diethylpropion

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • diphenoxylate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    diphenoxylate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + diphenoxylate

    separate admin. by 1h: combo may decr. hyoscyamine levels, efficacy; may incr. risk of CNS depression, psychomotor impairment, severe constipation, paralytic ileus (mechanism unknown; additive effects)

  • dobutamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + dobutamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • dopamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dopamine
    2 interactions

    Monitor/Modify Tx

    hyoscyamine + dopamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

    methylene blue oral + dopamine

    decr. dopamine initial dose to one tenth of usual dose w/in 2-3wk of methylene blue use: combo may incr. dopamine levels, duration of action, risk of adverse effects (monoamine oxidase (MAO) possibly inhibited)

  • droperidol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    droperidol
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + droperidol

    decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ephedrine injection
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + ephedrine injection

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ephedrine oral
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + ephedrine oral

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • epinephrine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + epinephrine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • esketamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + esketamine

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • eszopiclone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    eszopiclone
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + eszopiclone

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • etomidate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    etomidate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + etomidate

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • ferric maltol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ferric maltol
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + ferric maltol

    separate admin. w/ oral hyoscyamine by at least 4h: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • ferrous gluconate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ferrous gluconate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + ferrous gluconate

    separate admin. by 1h: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • ferrous sulfate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ferrous sulfate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + ferrous sulfate

    separate admin. by 1h: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • flecainide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    flecainide
    1 interaction

    Monitor/Modify Tx

    benzoic acid + flecainide

    monitor flecainide levels: combo may decr. flecainide levels, efficacy (renal excretion increased at lower urine pH)

  • fluphenazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + fluphenazine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • flurazepam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    flurazepam
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + flurazepam

    monitor respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • formoterol inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + formoterol inhaled

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • gabapentin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    gabapentin
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + gabapentin

    monitor respiratory rate; consider decreasing gabapentin dose: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • gabapentin enacarbil
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    gabapentin enacarbil
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + gabapentin enacarbil

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • gepirone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    gepirone
    1 interaction

    Monitor/Modify Tx

    methylene blue oral + gepirone

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • glycopyrrolate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    glycopyrrolate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + glycopyrrolate

    monitor HR: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • hoodia
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + hoodia

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • hydroxyzine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    hydroxyzine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + hydroxyzine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • ifosfamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + ifosfamide

    D/C one or both drugs if encephalopathy occurs; otherwise, caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • isoproterenol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    isoproterenol
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + isoproterenol

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ketamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + ketamine

    monitor respiratory rate, HR; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression (including life-threatening), psychomotor impairment, tachycardia (additive effects)

  • ketoconazole
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ketoconazole
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + ketoconazole

    give hyoscyamine at least 2h after ketoconazole; monitor for breakthrough fungal infection: combo may decr. ketoconazole levels, efficacy (gastric pH increased)

  • lanthanum
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lanthanum
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + lanthanum

    separate admin. w/ oral hyoscyamine by at least 2h: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • lemborexant
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lemborexant
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + lemborexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levalbuterol inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + levalbuterol inhaled

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • levoketoconazole
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    levoketoconazole
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + levoketoconazole

    admin. hyoscyamine at least 2h after levoketoconazole: combo may decr. levoketoconazole levels, efficacy (absorption decreased)

  • lifileucel
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lifileucel
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + lifileucel

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • liraglutide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + liraglutide

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • loperamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    loperamide
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + loperamide

    separate admin. by 1h: combo may decr. hyoscyamine levels, efficacy; may incr. risk of severe constipation, paralytic ileus (mechanism unknown; additive effects)

  • lorazepam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lorazepam
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + lorazepam

    monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • lumateperone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lumateperone
    2 interactions

    Monitor/Modify Tx

    methylene blue oral + lumateperone

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + lumateperone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • magnesium citrate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + magnesium citrate

    give oral hyoscyamine at least 2h before or 6h after magnesium citrate: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • magnesium oxide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    magnesium oxide
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + magnesium oxide

    separate admin. w/ oral hyoscyamine: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • magnesium supplement
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    magnesium supplement
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + magnesium supplement

    separate admin. w/ oral hyoscyamine: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • methotrexate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methotrexate
    1 interaction

    Monitor/Modify Tx

    benzoic acid + methotrexate

    monitor CBC, renal fxn: combo may incr. methotrexate levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (renal excretion decreased at lower urine pH)

  • methscopolamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methscopolamine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + methscopolamine

    monitor HR: combo may incr. risk of tachycardia, anticholinergic adverse effects (additive effects)

  • modafinil
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + modafinil

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • molindone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + molindone

    separate admin. w/ oral hyoscyamine: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects; may decr. hyoscyamine levels, efficacy (additive effects; absorption decreased via chelation, molindone contains calcium)

  • nefazodone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    nefazodone
    2 interactions

    Monitor/Modify Tx

    methylene blue oral + nefazodone

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

    Caution Advised

    hyoscyamine + nefazodone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • nelarabine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    nelarabine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + nelarabine

    withhold nelarabine if Grade 2 or greater somnolence occurs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • olodaterol inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + olodaterol inhaled

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • orphenadrine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    orphenadrine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + orphenadrine

    monitor HR: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • oxazepam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + oxazepam

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • oxybutynin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    oxybutynin
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + oxybutynin

    decr. dose of one or both drugs or consider oxybutynin transdermal patch: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects; somnolence less likely with oxybutynin transdermal patch (additive effects)

  • pentobarbital
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + pentobarbital

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • perphenazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + perphenazine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • phendimetrazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + phendimetrazine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • phenobarbital
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + phenobarbital

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • phentermine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + phentermine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • phenylephrine ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + phenylephrine ophthalmic

    monitor HR; risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of tachycardia (additive effects)

  • pregabalin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pregabalin
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + pregabalin

    monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • primidone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    primidone
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + primidone

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • probenecid
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    probenecid
    1 interaction

    Monitor/Modify Tx

    phenyl salicylate + probenecid

    monitor uric acid levels: combo may decr. probenecid efficacy (antagonistic effects)

  • propofol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + propofol

    monitor respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • pseudoephedrine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + pseudoephedrine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • quazepam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    quazepam
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + quazepam

    consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • quinapril
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + quinapril

    separate admin. w/ oral hyoscyamine: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation, quinapril contains magnesium)

  • remimazolam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + remimazolam

    monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • rotigotine transdermal
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + rotigotine transdermal

    monitor HR: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment (additive effects)

  • salmeterol inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + salmeterol inhaled

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • sevoflurane
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + sevoflurane

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • sincalide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sincalide
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + sincalide

    if sincalide gallbladder contraction stimulation use, consider D/C hyoscyamine prior to sincalide admin.: combo may alter sincalide efficacy, interfere with test results (gallbladder motility/contractility altered)

  • solriamfetol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + solriamfetol

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • sucralfate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sucralfate
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + sucralfate

    separate admin. by 1h: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • sucroferric oxyhydroxide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sucroferric oxyhydroxide
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + sucroferric oxyhydroxide

    separate admin. w/ oral hyoscyamine: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • sulfate bowel prep
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    sulfate bowel prep
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + sulfate bowel prep

    give oral hyoscyamine at least 2h before or 6h after bowel prep: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation, bowel prep contains magnesium)

  • suvorexant
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    suvorexant
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + suvorexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • terbutaline
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + terbutaline

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • thioridazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + thioridazine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects; may decr. phenothiazine efficacy (additive effects; antagonistic effects)

  • thiothixene
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + thiothixene

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • triazolam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    triazolam
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + triazolam

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • trospium
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    trospium
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + trospium

    monitor HR: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • vilanterol inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + vilanterol inhaled

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • viloxazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + viloxazine

    monitor HR: combo may incr. risk of tachycardia, CNS depression, psychomotor impairment (additive effects)

  • zaleplon
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    zaleplon
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + zaleplon

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ziconotide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ziconotide
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + ziconotide

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zinc oral
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    zinc oral
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + zinc oral

    give oral hyoscyamine at least 2h before or 4h after oral zinc salts: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation)

  • zolpidem
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    zolpidem
    1 interaction

    Monitor/Modify Tx

    hyoscyamine + zolpidem

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Caution Advised

  • aceclidine ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    aceclidine ophthalmic
    1 interaction

    Caution Advised

    hyoscyamine + aceclidine ophthalmic

    caution advised: combo may decr. aceclidine efficacy (antagonistic effects)

  • acetaminophen
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    acetaminophen
    1 interaction

    Caution Advised

    hyoscyamine + acetaminophen

    caution advised w/ oral acetaminophen: combo may decr. peak acetaminophen levels, delay analgesic onset, efficacy (absorption delayed, possibly decreased)

  • allopurinol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    allopurinol
    1 interaction

    Caution Advised

    hyoscyamine + allopurinol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • alosetron
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    alosetron
    1 interaction

    Caution Advised

    hyoscyamine + alosetron

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • amantadine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    amantadine
    2 interactions

    Caution Advised

    benzoic acid + amantadine

    caution advised: combo may decr. amantadine levels, efficacy (renal excretion increased at lower urine pH)

    hyoscyamine + amantadine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • apomorphine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    apomorphine
    1 interaction

    Caution Advised

    hyoscyamine + apomorphine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • apraclonidine ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    apraclonidine ophthalmic
    1 interaction

    Caution Advised

    hyoscyamine + apraclonidine ophthalmic

    caution advised if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • aripiprazole bimonthly injection
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    aripiprazole bimonthly injection
    1 interaction

    Caution Advised

    hyoscyamine + aripiprazole bimonthly injection

    caution advised: combo may incr. risk of hyperthermia, CNS depression, psychomotor impairment (additive effects)

  • aripiprazole lauroxil
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    aripiprazole lauroxil
    1 interaction

    Caution Advised

    hyoscyamine + aripiprazole lauroxil

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • aripiprazole monthly injection
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    aripiprazole monthly injection
    1 interaction

    Caution Advised

    hyoscyamine + aripiprazole monthly injection

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • aripiprazole oral
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    aripiprazole oral
    1 interaction

    Caution Advised

    hyoscyamine + aripiprazole oral

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • asenapine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    asenapine
    1 interaction

    Caution Advised

    hyoscyamine + asenapine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • aspirin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    aspirin
    1 interaction

    Caution Advised

    phenyl salicylate + aspirin

    caution advised: combo may incr. salicylate levels, risk of adverse effects (additive effects, duplicate therapy)

  • atropine ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    atropine ophthalmic
    1 interaction

    Caution Advised

    hyoscyamine + atropine ophthalmic

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • baclofen
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    baclofen
    1 interaction

    Caution Advised

    hyoscyamine + baclofen

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • baclofen intrathecal
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    baclofen intrathecal
    1 interaction

    Caution Advised

    hyoscyamine + baclofen intrathecal

    caution advised: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • barium
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    barium
    1 interaction

    Caution Advised

    hyoscyamine + barium

    caution advised: combo may incr. risk of intestinal obstruction (additive effects)

  • bethanechol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    bethanechol
    1 interaction

    Caution Advised

    hyoscyamine + bethanechol

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • botulinum toxin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    botulinum toxin
    1 interaction

    Caution Advised

    hyoscyamine + botulinum toxin

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • brexpiprazole
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    brexpiprazole
    1 interaction

    Caution Advised

    hyoscyamine + brexpiprazole

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • brimonidine ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    brimonidine ophthalmic
    1 interaction

    Caution Advised

    hyoscyamine + brimonidine ophthalmic

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • brivaracetam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    brivaracetam
    1 interaction

    Caution Advised

    hyoscyamine + brivaracetam

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • brompheniramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    brompheniramine
    1 interaction

    Caution Advised

    hyoscyamine + brompheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • cannabidiol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cannabidiol
    1 interaction

    Caution Advised

    hyoscyamine + cannabidiol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • carbinoxamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    carbinoxamine
    1 interaction

    Caution Advised

    hyoscyamine + carbinoxamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • cariprazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cariprazine
    1 interaction

    Caution Advised

    hyoscyamine + cariprazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • carisoprodol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    carisoprodol
    1 interaction

    Caution Advised

    hyoscyamine + carisoprodol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • cenobamate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cenobamate
    1 interaction

    Caution Advised

    hyoscyamine + cenobamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • cetirizine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cetirizine
    1 interaction

    Caution Advised

    hyoscyamine + cetirizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • cevimeline
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cevimeline
    1 interaction

    Caution Advised

    hyoscyamine + cevimeline

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • chamomile, German
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    chamomile, German
    1 interaction

    Caution Advised

    hyoscyamine + chamomile, German

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chlophedianol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    chlophedianol
    1 interaction

    Caution Advised

    hyoscyamine + chlophedianol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • chlorcyclizine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    chlorcyclizine
    1 interaction

    Caution Advised

    hyoscyamine + chlorcyclizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • chlordiazepoxide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    chlordiazepoxide
    1 interaction

    Caution Advised

    hyoscyamine + chlordiazepoxide

    caution advised: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • chlorpheniramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    chlorpheniramine
    1 interaction

    Caution Advised

    hyoscyamine + chlorpheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • chlorzoxazone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    chlorzoxazone
    1 interaction

    Caution Advised

    hyoscyamine + chlorzoxazone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • cisapride
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cisapride
    1 interaction

    Caution Advised

    hyoscyamine + cisapride

    caution advised: combo may decr. cisapride efficacy (antagonistic effects)

  • clemastine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    clemastine
    1 interaction

    Caution Advised

    hyoscyamine + clemastine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • clidinium
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    clidinium
    1 interaction

    Caution Advised

    hyoscyamine + clidinium

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • cyclopentolate ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cyclopentolate ophthalmic
    1 interaction

    Caution Advised

    hyoscyamine + cyclopentolate ophthalmic

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • cyproheptadine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    cyproheptadine
    1 interaction

    Caution Advised

    hyoscyamine + cyproheptadine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • dantrolene
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dantrolene
    1 interaction

    Caution Advised

    hyoscyamine + dantrolene

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • darifenacin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    darifenacin
    1 interaction

    Caution Advised

    hyoscyamine + darifenacin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • dexbrompheniramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dexbrompheniramine
    1 interaction

    Caution Advised

    hyoscyamine + dexbrompheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • dexchlorpheniramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dexchlorpheniramine
    1 interaction

    Caution Advised

    hyoscyamine + dexchlorpheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • difelikefalin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    difelikefalin
    1 interaction

    Caution Advised

    hyoscyamine + difelikefalin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • difenoxin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    difenoxin
    1 interaction

    Caution Advised

    hyoscyamine + difenoxin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, severe constipation, paralytic ileus (additive effects)

  • dimenhydrinate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    dimenhydrinate
    1 interaction

    Caution Advised

    hyoscyamine + dimenhydrinate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • diphenhydramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    diphenhydramine
    1 interaction

    Caution Advised

    hyoscyamine + diphenhydramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • disopyramide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    disopyramide
    1 interaction

    Caution Advised

    hyoscyamine + disopyramide

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • domperidone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    domperidone
    1 interaction

    Caution Advised

    hyoscyamine + domperidone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may decr. domperidone efficacy (additive effects; antagonistic effects)

  • donepezil
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    donepezil
    1 interaction

    Caution Advised

    hyoscyamine + donepezil

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • doxazosin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    doxazosin
    1 interaction

    Caution Advised

    hyoscyamine + doxazosin

    caution advised w/ doxazosin ER dosage form: combo may incr. doxazosin levels, risk of adverse effects (absorption increased)

  • efavirenz
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    efavirenz
    1 interaction

    Caution Advised

    hyoscyamine + efavirenz

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • elinzanetant
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    elinzanetant
    1 interaction

    Caution Advised

    hyoscyamine + elinzanetant

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • entrectinib
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    entrectinib
    1 interaction

    Caution Advised

    hyoscyamine + entrectinib

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • erenumab
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    erenumab
    1 interaction

    Caution Advised

    hyoscyamine + erenumab

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • erythromycin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    erythromycin
    1 interaction

    Caution Advised

    hyoscyamine + erythromycin

    caution advised: combo may decr. erythromycin efficacy when used for GI promotility (antagonistic effects)

  • eslicarbazepine acetate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    eslicarbazepine acetate
    1 interaction

    Caution Advised

    hyoscyamine + eslicarbazepine acetate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • estazolam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    estazolam
    1 interaction

    Caution Advised

    hyoscyamine + estazolam

    caution advised: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • ethanol (in some formulations)
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ethanol (in some formulations)
    1 interaction

    Caution Advised

    hyoscyamine + ethanol (in some formulations)

    caution advised: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • ethosuximide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ethosuximide
    1 interaction

    Caution Advised

    hyoscyamine + ethosuximide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • felbamate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    felbamate
    1 interaction

    Caution Advised

    hyoscyamine + felbamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • fesoterodine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    fesoterodine
    1 interaction

    Caution Advised

    hyoscyamine + fesoterodine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • flavoxate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    flavoxate
    1 interaction

    Caution Advised

    hyoscyamine + flavoxate

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • flibanserin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    flibanserin
    1 interaction

    Caution Advised

    hyoscyamine + flibanserin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • foslevodopa
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    foslevodopa
    1 interaction

    Caution Advised

    hyoscyamine + foslevodopa

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • fosphenytoin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    fosphenytoin
    1 interaction

    Caution Advised

    hyoscyamine + fosphenytoin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • galantamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    galantamine
    1 interaction

    Caution Advised

    hyoscyamine + galantamine

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • ganaxolone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ganaxolone
    1 interaction

    Caution Advised

    hyoscyamine + ganaxolone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • gepotidacin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    gepotidacin
    1 interaction

    Caution Advised

    hyoscyamine + gepotidacin

    caution advised: combo may decr. hyoscyamine efficacy (antagonistic effects, gepotidacin reversibly inhibits acetylcholinesterase)

  • glofitamab
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    glofitamab
    1 interaction

    Caution Advised

    hyoscyamine + glofitamab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • glycopyrrolate inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    glycopyrrolate inhaled
    1 interaction

    Caution Advised

    hyoscyamine + glycopyrrolate inhaled

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • guanfacine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    guanfacine
    1 interaction

    Caution Advised

    hyoscyamine + guanfacine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • homatropine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    homatropine
    1 interaction

    Caution Advised

    hyoscyamine + homatropine

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • iloperidone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    iloperidone
    1 interaction

    Caution Advised

    hyoscyamine + iloperidone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ipratropium inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ipratropium inhaled
    1 interaction

    Caution Advised

    hyoscyamine + ipratropium inhaled

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • ipratropium nasal
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ipratropium nasal
    1 interaction

    Caution Advised

    hyoscyamine + ipratropium nasal

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • isoflurane
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    isoflurane
    1 interaction

    Caution Advised

    hyoscyamine + isoflurane

    caution advised: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • lacosamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lacosamide
    1 interaction

    Caution Advised

    hyoscyamine + lacosamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • lamotrigine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lamotrigine
    1 interaction

    Caution Advised

    hyoscyamine + lamotrigine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levetiracetam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    levetiracetam
    1 interaction

    Caution Advised

    hyoscyamine + levetiracetam

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levocetirizine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    levocetirizine
    1 interaction

    Caution Advised

    hyoscyamine + levocetirizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levodopa
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    levodopa
    1 interaction

    Caution Advised

    hyoscyamine + levodopa

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • linvoseltamab
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    hyoscyamine + linvoseltamab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • lofexidine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lofexidine
    1 interaction

    Caution Advised

    hyoscyamine + lofexidine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • loxapine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    loxapine
    1 interaction

    Caution Advised

    hyoscyamine + loxapine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • lurasidone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    lurasidone
    1 interaction

    Caution Advised

    hyoscyamine + lurasidone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • meclizine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    meclizine
    1 interaction

    Caution Advised

    hyoscyamine + meclizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • melatonin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    melatonin
    1 interaction

    Caution Advised

    hyoscyamine + melatonin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • meprobamate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    meprobamate
    1 interaction

    Caution Advised

    hyoscyamine + meprobamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methacholine inhaled
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methacholine inhaled
    1 interaction

    Caution Advised

    hyoscyamine + methacholine inhaled

    caution advised: combo may interfere with test results (antagonistic effects)

  • methocarbamol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methocarbamol
    1 interaction

    Caution Advised

    hyoscyamine + methocarbamol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methohexital
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methohexital
    1 interaction

    Caution Advised

    hyoscyamine + methohexital

    caution advised: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • methsuximide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methsuximide
    1 interaction

    Caution Advised

    hyoscyamine + methsuximide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methyldopa
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    methyldopa
    1 interaction

    Caution Advised

    hyoscyamine + methyldopa

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • metyrapone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    metyrapone
    1 interaction

    Caution Advised

    hyoscyamine + metyrapone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • metyrosine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    metyrosine
    1 interaction

    Caution Advised

    hyoscyamine + metyrosine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • milsaperidone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    milsaperidone
    1 interaction

    Caution Advised

    hyoscyamine + milsaperidone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • mirabegron
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    mirabegron
    1 interaction

    Caution Advised

    hyoscyamine + mirabegron

    caution advised: combo may incr. risk of urinary retention (additive effects)

  • mitotane
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    mitotane
    1 interaction

    Caution Advised

    hyoscyamine + mitotane

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mosunetuzumab
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    hyoscyamine + mosunetuzumab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mycophenolate mofetil
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    mycophenolate mofetil
    1 interaction

    Caution Advised

    hyoscyamine + mycophenolate mofetil

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • naltrexone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    naltrexone
    1 interaction

    Caution Advised

    hyoscyamine + naltrexone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • naphazoline ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    naphazoline ophthalmic
    1 interaction

    Caution Advised

    hyoscyamine + naphazoline ophthalmic

    caution advised: combo with anticholinergics may incr. risk of exaggerated adrenergic effects of ophthalmic decongestants (mechanism unknown)

  • neostigmine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    neostigmine
    1 interaction

    Caution Advised

    hyoscyamine + neostigmine

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • oxcarbazepine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    oxcarbazepine
    1 interaction

    Caution Advised

    hyoscyamine + oxcarbazepine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • paliperidone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    paliperidone
    1 interaction

    Caution Advised

    hyoscyamine + paliperidone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • passion flower
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    passion flower
    1 interaction

    Caution Advised

    hyoscyamine + passion flower

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • perampanel
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    perampanel
    1 interaction

    Caution Advised

    hyoscyamine + perampanel

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • pheniramine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pheniramine
    1 interaction

    Caution Advised

    hyoscyamine + pheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • phenytoin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    phenytoin
    1 interaction

    Caution Advised

    hyoscyamine + phenytoin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • pilocarpine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pilocarpine
    1 interaction

    Caution Advised

    hyoscyamine + pilocarpine

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • pilocarpine ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pilocarpine ophthalmic
    1 interaction

    Caution Advised

    hyoscyamine + pilocarpine ophthalmic

    caution advised: combo may decr. pilocarpine efficacy (antagonistic effects)

  • pimozide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pimozide
    1 interaction

    Caution Advised

    hyoscyamine + pimozide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • potassium acid phosphate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    potassium acid phosphate
    1 interaction

    Caution Advised

    hyoscyamine + potassium acid phosphate

    caution advised w/ solid potassium formulations; liquid potassium formulations OK: combo may incr. risk of GI ulcerative, stenotic lesions (GI transit delayed, increased local exposure to high potassium concentration)

  • potassium gluconate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    potassium gluconate
    1 interaction

    Caution Advised

    hyoscyamine + potassium gluconate

    caution advised w/ solid potassium formulations; liquid potassium formulations OK: combo may incr. risk of GI ulcerative, stenotic lesions (GI transit delayed, increased local exposure to high potassium concentration)

  • potassium phosphate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    potassium phosphate
    1 interaction

    Caution Advised

    hyoscyamine + potassium phosphate

    caution advised w/ solid potassium formulations; liquid potassium formulations OK: combo may incr. risk of GI ulcerative, stenotic lesions (GI transit delayed, increased local exposure to high potassium concentration)

  • pramipexole
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pramipexole
    1 interaction

    Caution Advised

    hyoscyamine + pramipexole

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • procainamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    procainamide
    1 interaction

    Caution Advised

    hyoscyamine + procainamide

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • prochlorperazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    prochlorperazine
    1 interaction

    Caution Advised

    hyoscyamine + prochlorperazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects; may decr. prochlorperazine efficacy (additive effects; antagonistic effects)

  • pyridostigmine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pyridostigmine
    1 interaction

    Caution Advised

    hyoscyamine + pyridostigmine

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • pyrilamine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    pyrilamine
    1 interaction

    Caution Advised

    hyoscyamine + pyrilamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • quetiapine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    quetiapine
    1 interaction

    Caution Advised

    hyoscyamine + quetiapine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, anticholinergic adverse effects (additive effects)

  • quinidine (antiarrhythmic)
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Caution Advised

    hyoscyamine + quinidine (antiarrhythmic)

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • quinidine (CYP2D6 inhibitor)
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Caution Advised

    hyoscyamine + quinidine (CYP2D6 inhibitor)

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • ramelteon
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ramelteon
    1 interaction

    Caution Advised

    hyoscyamine + ramelteon

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • repotrectinib
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    repotrectinib
    1 interaction

    Caution Advised

    hyoscyamine + repotrectinib

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • risperidone
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    risperidone
    1 interaction

    Caution Advised

    hyoscyamine + risperidone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ropinirole
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    ropinirole
    1 interaction

    Caution Advised

    hyoscyamine + ropinirole

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • rufinamide
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    rufinamide
    1 interaction

    Caution Advised

    hyoscyamine + rufinamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • salsalate
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    salsalate
    1 interaction

    Caution Advised

    benzoic acid + salsalate

    caution advised: combo may increase salsalate levels, risk of adverse effects (renal excretion decreased at lower urine pH)

  • selinexor
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    selinexor
    1 interaction

    Caution Advised

    hyoscyamine + selinexor

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • solifenacin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    solifenacin
    1 interaction

    Caution Advised

    hyoscyamine + solifenacin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • stiripentol
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    stiripentol
    1 interaction

    Caution Advised

    hyoscyamine + stiripentol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tasimelteon
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tasimelteon
    1 interaction

    Caution Advised

    hyoscyamine + tasimelteon

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • temazepam
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    temazepam
    1 interaction

    Caution Advised

    hyoscyamine + temazepam

    caution advised: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • tetrahydrozoline ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tetrahydrozoline ophthalmic
    1 interaction

    Caution Advised

    hyoscyamine + tetrahydrozoline ophthalmic

    caution advised: combo with anticholinergics may incr. risk of exaggerated adrenergic effects of ophthalmic decongestants (mechanism unknown)

  • thiotepa
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    thiotepa
    1 interaction

    Caution Advised

    hyoscyamine + thiotepa

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tiagabine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tiagabine
    1 interaction

    Caution Advised

    hyoscyamine + tiagabine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tizanidine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tizanidine
    1 interaction

    Caution Advised

    hyoscyamine + tizanidine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tolterodine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tolterodine
    1 interaction

    Caution Advised

    hyoscyamine + tolterodine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • trifluoperazine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    trifluoperazine
    1 interaction

    Caution Advised

    hyoscyamine + trifluoperazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects; may decr. phenothiazine efficacy (additive effects; antagonistic effects)

  • trihexyphenidyl
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    trihexyphenidyl
    1 interaction

    Caution Advised

    hyoscyamine + trihexyphenidyl

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, anticholinergic adverse effects (additive effects)

  • triprolidine
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    triprolidine
    1 interaction

    Caution Advised

    hyoscyamine + triprolidine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

  • tropicamide ophthalmic
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    tropicamide ophthalmic
    1 interaction

    Caution Advised

    hyoscyamine + tropicamide ophthalmic

    caution advised: combo may incr. risk of anticholinergic adverse effects (additive effects)

  • valerian
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    valerian
    1 interaction

    Caution Advised

    hyoscyamine + valerian

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • valproic acid
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    valproic acid
    1 interaction

    Caution Advised

    hyoscyamine + valproic acid

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • vibegron
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    vibegron
    1 interaction

    Caution Advised

    hyoscyamine + vibegron

    caution advised: combo may incr. risk of urinary retention (additive effects)

  • vigabatrin
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    vigabatrin
    1 interaction

    Caution Advised

    hyoscyamine + vigabatrin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • willow bark
  • Uribel Tabs (methenamine/ benzoic acid/ phenyl salicylate/ methylene blue/ hyoscyamine)
    +
    willow bark
    1 interaction

    Caution Advised

    phenyl salicylate + willow bark

    caution advised: combo may incr. risk of salicylate-related adverse effects (additive effects, duplicate therapy, willow bark may contain salicylates)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@5a05e827
  • hypersensitivity reaction
  • anaphylaxis
  • crystalluria
  • hemolytic anemia
  • serotonin syndrome
  • syncope
  • heat stroke
  • IOP incr.
  • psychosis, anticholinergic
  • hallucinations

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@6c65b5ca
  • tachycardia
  • flushing
  • dyspnea
  • dry mouth
  • nausea
  • vomiting
  • drowsiness
  • dizziness
  • blurred vision
  • urinary retention
  • difficulty urinating
  • urine discoloration
  • fecal discoloration
  • anticholinergic effects

Safety/Monitoring .

Monitoring Parameters
no routine tests recommended

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; risk of fetal harm low based on limited human data with methenamine, methylene blue, or hyoscyamine; no human data available with benzoic acid or phenyl salicylate

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no known risk of infant harm based on limited human data with methenamine; no human data available to assess risk of infant harm with benzoic acid, phenyl salicylate, methylene blue, or hyoscyamine; no human data available, though theoretical risk of decr. milk production based on decr. prolactin levels with hyoscyamine

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@765138c8

Metabolism: for methenamine: urine; CYP450: unknown; Info: active metabolite (formaldehyde); for benzoic acid: liver; CYP450: unknown; for phenyl salicylate: liver; CYP450: unknown; Info: active metabolite (salicylate); for methylene blue: liver extensively; CYP450: 1A2, 2C19, 2D6 substrate; UGT: 1A4, 1A9 substrate; Info: active metabolite; for hyoscyamine: liver; CYP450: unknown

Excretion: for methenamine: urine >90%; Half-life: 4.3h; for benzoic acid: urine; Half-life: unknown; for phenyl salicylate: urine; Half-life: unknown; for methylene blue: urine (40% unchanged), bile; Half-life: 24h; for hyoscyamine: urine primarily (30-50% unchanged); Half-life: 2-3.5h

Subclass: Analgesics, Urinary ; Antiseptics, Urinary ; Urinary Acidifiers

Mechanism of Action
for methenamine: prodrug hydrolyzed to formaldehyde and ammonia in acidic urine, exerting non-specific antibacterial effects via formaldehyde protein denaturation; for benzoic acid: acidifies urine; for phenyl salicylate: hydrolyzes to salicylate, inhibiting cyclooxygenase to produce analgesia; for methylene blue: possesses weak antiseptic activity; for hyoscyamine: antagonizes acetylcholine receptors, producing antispasmodic effects (anticholinergic)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Mission Pharmacal Company

com.epocrates.rxweb.beans.DrugOtherInfoBean@4c057e1c

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information